查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722628

心血管設備市場報告（按設備類型、應用（冠狀動脈疾病、心律不整、心臟衰竭等）、最終用戶和地區）2025 年至 2033 年

Cardiovascular Devices Market Report by Device Type, Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, and Others), End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年全球心血管設備市場規模達623億美元。展望未來， IMARC Group預計到2033年市場規模將達到1,013億美元，2025-2033年期間的成長率（CAGR）為5.5%。介入性心臟病學程序的引入，加上優惠的報銷政策，正在刺激市場成長。

心血管設備市場分析：

主要市場促進因素：心血管疾病（如心臟衰竭、冠狀動脈疾病、心律不整等）的增加正在推動市場的發展。此外，消費者越來越傾向於採用微創替代傳統開胸心臟手術，以實現更快的康復、減少住院時間、提高患者的舒適度等，這也是另一個重要的成長誘導因素。

主要市場趨勢：3D 列印和人工智慧 (AI) 技術的不斷進步推動了先進心血管設備的推出，從而提供了更高的精度和安全性，這是刺激整個市場的新興趨勢之一。

地理趨勢：發達的醫療保健基礎設施正在支撐北美市場。除此之外，主要醫療器材製造商的存在和研發活動投資的增加也對區域市場產生了進一步的正面影響。

競爭格局：根據心血管設備市場概況，全球市場上的一些知名公司包括雅培實驗室、B. Braun Melsungen AG、Biotronik、波士頓科學公司、佳能醫療系統公司、Cardinal Health Inc.、Edwards Lifesciences Corporation、通用電氣公司、LivaNova PLC、美敦力公司、西門子醫療公司（西門子公司）和 Terumrum 公司（西門子）公司（西門子公司）。

挑戰與機會：心血管設備的推出涉及複雜的工程和先進材料的整合，這可能會阻礙市場成長。然而，關鍵參與者正在確保這些設備（尤其是植入式設備）的長期可靠性和安全性。這反過來將在未來幾年繼續擴大全球市場。

心血管設備市場趨勢：

對微創手術的需求

人們的偏好從傳統的開胸心臟手術轉向侵入性較小的手術方法，以最大程度地縮短恢復時間、降低手術風險、改善患者預後等，這刺激了市場的發展。例如，2024 年 4 月，由戈爾韋大學研究小組監督的 FAST TRACK CABG 研究首次測試了一種針對患者進行心臟搭橋手術的規劃、指導和實施的新方法。這證明了採用人工智慧血流掃描的非侵入性心臟CT是可行且安全的。除此之外，機器人和即時成像技術的廣泛應用使得無需進行大切口即可準確放置瓣膜、支架和其他設備，這也提高了心血管設備市場的收入。例如，2024 年 2 月，飛利浦推出了採用 Fiber Optic RealShape (FORS) 技術的 LumiGuide，可實現無輻射、微創手術。除此之外，微創手術是使用專門的心血管器械和先進的成像技術透過小切口進行的，可以實現有針對性的精確治療。一些常見的例子包括經導管二尖瓣修復術 (TMVR)、經導管主動脈瓣置換術 (TAVR)、內視鏡靜脈採集等。因此，它們在全球範圍內越來越受歡迎。例如，2022 年 12 月，全球領先的醫療保健公司之一雅培宣布推出其新型經導管主動脈瓣植入 (TAVI) 系統 N​​avitor，面向印度患有嚴重主動脈瓣狹窄且手術風險高或極高的患者。隨著技術的進步，這些程序變得越來越有效和越來越安全，從而導致其在治療各種心血管疾病方面的應用越來越廣泛。例如，2024年5月，根據心血管造影和介入學會（SCAI）年會上公佈的一年新資料，Anteris Technologies公司開發的新型仿生經導管主動脈瓣置換術（TAVR）系統可以為心臟科醫生提供治療重度主動脈瓣狹窄（AS）的新方法。

增強型變異體的引入

心血管設備在慢性心臟病和中風的治療、診斷和管理中發揮著至關重要的作用。因此，主要參與者正在推出新型設備，使醫療專業人員能夠準確評估心血管疾病的嚴重程度、監測患者的心臟健康、改善有效治療方法等。此外，需要介入治療心血管疾病的患者數量不斷增加，智慧支架、植入式心律調節器、除顫器等設備的普及率也不斷增加。這反過來又對心血管設備市場前景產生了正面影響。例如，2023 年 12 月，Terumo India 宣布推出 Ultimaster Nagomi，這是一種用於治療冠狀動脈疾病的藥物洗脫支架。除此之外，不斷增加的研發投資以推出改良的心血管設備（包括心律調節器）也是重要的成長誘導因素。例如，2023 年 5 月，心律管理領域的全球開發商之一微創醫療的多種植入式心律調節器 Alizea 和 Celea 獲得了 FDA 批准。此外，它們還具有微創發明的演算法 AutoMRI 模式，可提高接受 MRI 檢查的患者的安全性。同樣，2023 年 7 月，雅培宣布 FDA 批准其無導線心律調節器系統 Aveir DR。此外，機器學習和人工智慧也用於分析大量心血管資料，以製定個人化治療計劃、預測患者預後、提高診斷準確性等。例如，2024 年 1 月，美國梅奧診所心臟病專家 Demilade Adedinsewo 博士領導的研究表明，人工智慧數位聽診器可以改善圍產期心肌病變的診斷，這是一種可能危及生命的疾病，會在懷孕期間削弱女性的心肌。

策略夥伴關係

知名公司、醫療器材製造商、研究機構和醫療保健組織正在合作並進行併購活動，以引進心血管設備，包括精密影像工具。這是心血管設備市場近期的機會之一。例如，2023 年 9 月，領先的心臟資料管理平台之一 PaceMate 宣布與 MedAxiom 合作，在單一雲端原生環境中為心臟和 EHR資料創建工作流程解決方案。與此相符，2023年10月，GE醫療與波士頓科學公司合作開發增強型心臟影像系統。此外，這些合作夥伴關係可協助公司利用合作夥伴的本地專業知識和已建立的經銷網路，應對複雜的監管環境並進入國際市場。例如，2023 年 6 月，飛利浦與 Biotronik 建立合作夥伴關係，以擴大飛利浦 SymphonySuite 客戶可用的心血管設備範圍。除此之外，2023 年 5 月，PaceMate 與 FDA 批准的個人心電圖技術和遠端病患管理解決方案的全球領導者之一 AliveCor 合作，推出可植入心臟裝置。

心血管設備市場細分：

依設備類型細分：

  • 診斷和監測設備
  • 心電圖（ECG）
  • 遠端心臟監測
  • 其他
  • 治療及外科手術設備
  • 心律管理 (CRM) 設備
  • 導管
  • 支架
  • 心臟瓣膜
  • 其他

治療和手術設備是最受歡迎的設備類型

旨在治療心血管疾病的外科手術和治療干預的數量不斷增加，推動了該領域的成長。此外，治療和手術設備包括植入式心律轉復除顫器 (ICD)、支架、心律調節器、導管、心臟瓣膜、心室輔助裝置 (VAD) 等。它們有助於調節心律、恢復血流、提供機械循環支持等。因此，它們作為傳統開胸手術的微創替代方案，正獲得廣泛的關注，從而提升了心血管設備的市場需求。例如，2023 年 12 月，全球醫療技術領導者之一美敦力公司宣布 FDA 批准 PulseSelect 脈衝場消融 (PFA) 系統用於治療陣發性和持續性心房顫動 (AF)。與此相符，Magenta Medical 於 2023 年 6 月啟動了世界上最小的心臟幫浦的可行性研究，可減少心臟手術期間的血管通路併發症。

按應用分類：

  • 冠狀動脈疾病（CAD）
  • 心律不整
  • 心臟衰竭
  • 其他

冠狀動脈疾病（CAD）佔據心血管設備市場佔有率的主導地位

用於治療、診斷和管理冠狀動脈疾病的 CAD 設備在各國越來越受歡迎。此外，血管內超音波 (IVUS) 設備、血管造影系統和電腦斷層血管攝影 (CTA) 機器等診斷設備的廣泛採用正在推動市場的發展，因為它們有助於評估冠狀動脈阻塞的嚴重程度。例如，2022 年 8 月，美敦力宣布推出其新型藥物洗脫冠狀動脈支架 Onyx Frontier 藥物洗脫支架 (DES)，該產品已獲得 CE 標誌批准。除此之外，致力於創建心臟病診斷新護理標準的公司之一 Cleerly 於 2024 年 1 月推出了 Cleerly ISCHEMIA，該產品最近獲得了美國食品藥品監督管理局 (FDA) 510(k) 醫療器材許可。 Cleerly ISCHEMIA 分析軟體是一款基於機器學習的自動化決策支援工具，專為接受冠狀動脈電腦斷層血管攝影 (CCTA) 的患者設計。

按最終用戶分類：

  • 醫院
  • 專科診所
  • 其他

醫院佔據了整體市場佔有率的大部分

醫院是心血管設備的主要最終使用者。他們提供廣泛的心臟服務，例如心血管疾病的治療、診斷和外科手術。醫院設有心臟導管實驗室和專門的心臟科室，配備先進的影像系統和手術室，這提高了心血管設備市場的近期價格。例如，2024年1月，安大略省衛生部長西爾維亞瓊斯宣佈在加拿大基奇納的聖瑪麗綜合醫院建立一個新的心臟實驗室，以幫助心臟病患者。他們需要全方位的設備，例如植入式設備、診斷設備、手術器械、監測系統等，這推動了該細分市場的成長。

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

北美在市場上佔據明顯主導地位

市場研究報告也對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。根據報告，北美是心血管設備最大的市場。

中風和周邊動脈疾病等心血管疾病的盛行率不斷上升，推動了區域市場的發展。例如，根據加拿大心臟和中風基金會2022年2月發布的報告，有75萬名患者被診斷出心臟衰竭。此外，有利的報銷政策和快速的法規核准也是重要的成長誘因。例如，2023 年 9 月，CorVista Health 宣布 FDA 批准其用於檢測心臟病的非侵入性醫療設備系統。與此相符的是，2024年1月，專注於結構性心臟病的瑞典醫療器材公司Occlutech的ASD封堵器獲得美國FDA批准，用於治療心房中隔缺損（ASD）。除此之外，根據心血管設備市場統計數據，無線心電圖的引入使得即時患者監測和診斷成為可能。這反過來將在未來幾年繼續刺激區域市場。例如，2021 年 2 月，VivaLNK 開發了一款穿戴式心電圖監測解決方案，旨在以無線方式捕捉六分鐘步行測試 (6MWT) 期間的心電圖和心率。

競爭格局：

主要參與者正大力投資研發創新心血管設備。他們專注於提高設備性能、耐用性和患者治療效果。研發工作旨在引進先進技術，例如微創手術、遠端監控系統和個人化醫療方法。此外，心血管設備市場公司正在不斷推出新的心血管設備以擴大其產品組合。這些發布通常涉及具有改進功能和增強性能的下一代設備。他們優先解決未滿足的臨床需求，例如針對特定心血管疾病的新療法或提供更高精確度和易用性的設備。除此之外，心血管設備市場中主要參與者、醫療保健提供者和研究機構之間的合作與夥伴關係也很常見。這些合作促進了創新，促進了知識交流，並利用集體的專業知識和資源來開發和商業化新技術和解決方案。

市場研究報告對競爭格局進行了全面的分析。也提供了所有主要公司的詳細資料。市場中的一些主要參與者包括：

  • 雅培實驗室
  • B. Braun Melsungen AG
  • 百多力
  • 波士頓科學公司
  • 佳能醫療系統株式會社
  • 康德樂公司
  • 愛德華生命科學公司
  • 通用電氣公司
  • LivaNova 有限公司
  • 美敦力公司
  • 西門子醫療股份有限公司（西門子股份公司）
  • 泰爾茂心血管系統株式會社（Terumo Corporation）

本報告回答的關鍵問題

  • 2024年全球心血管設備市場規模是多少
  • 2025-2033年全球心血管設備市場的預期成長率是多少
  • COVID-19 對全球心血管設備市場有何影響
  • 推動全球心血管設備市場的關鍵因素有哪些
  • 根據設備類型，全球心血管設備市場如何分類
  • 根據應用，全球心血管設備市場如何分類
  • 根據最終用戶，全球心血管設備市場如何分類
  • 全球心血管設備市場的主要區域有哪些
  • 全球心血管設備市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024 年全球心血管設備市場規模？ 2025-2033年全球心血管設備市場的預期成長率是多少？
  • COVID-19 對全球心血管設備市場有何影響？
  • 推動全球心血管設備市場發展的關鍵因素有哪些？
  • 根據設備類型，全球心血管設備市場是如何分類的？
  • 根據應用，全球心血管設備市場如何分佈？
  • 根據最終用戶，全球心血管設備市場是如何分佈的？
  • 全球心血管設備市場的主要區域有哪些？
  • 全球心血管設備市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球心血管設備市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依設備類型

  • 診斷和監測設備
    • 關鍵部分
      • 心電圖（ECG）
      • 遠端心臟監測
      • 其他
  • 治療及外科手術設備
    • 關鍵部分
      • 心律管理 (CRM) 設備
      • 導管
      • 支架
      • 心臟瓣膜
      • 其他

第7章：市場區隔：依應用

  • 冠狀動脈疾病（CAD）
  • 心律不整
  • 心臟衰竭
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院
  • 專科診所
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • Cardinal Health Inc.
    • Edwards Lifesciences Corporation
    • General Electric Company
    • LivaNova PLC
    • Medtronic PLC
    • Siemens Healthineers GmbH (Siemens AG)
    • Terumo Cardiovascular Systems Corporation (Terumo Corporation)
Product Code: SR112025A5240

The global cardiovascular devices market size reached USD 62.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 101.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth.

Cardiovascular Devices Market Analysis:

Major Market Drivers: The increasing number of cardiovascular conditions, such as heart failure, coronary artery disease, arrhythmias, etc., is propelling the market. Moreover, the rising consumer inclination towards minimally invasive alternatives to traditional open-heart surgeries for faster recovery, reduced hospital stays, improved patient comfort, etc., is also acting as another significant growth-inducing factor.

Key Market Trends: The growing advancements in 3D printing and artificial intelligence (AI) technologies that are leading to the launch of advanced cardiovascular devices to offer enhanced precision and safety are among the emerging trends stimulating the overall market.

Geographical Trends: The well-developed healthcare infrastructures are bolstering the market in North America. Apart from this, the presence of major medical device manufacturers and the elevating investments in R&D activities are further positively influencing the regional market.

Competitive Landscape: According to the cardiovascular devices market overview, some of the prominent companies across the global market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG), and Terumo Cardiovascular Systems Corporation (Terumo Corporation), among many others.

Challenges and Opportunities: The launch of cardiovascular devices involves complex engineering and integration of advanced materials, which can hamper the market growth. However, key players are ensuring the long-term reliability and safety of these devices, particularly those that are implantable. This, in turn, will continue to augment the global market in the coming years.

Cardiovascular Devices Market Trends:

Demand for Minimally Invasive Procedures

The shifting preferences of individuals from traditional open-heart surgeries toward less invasive methodologies that minimize recovery times, reduce surgical risks, improve patient outcomes, etc., are stimulating the market. For example, in April 2024, the FAST TRACK CABG study, overseen by a team of researchers at the University of Galway, tested a new approach to the planning, guidance, and conducting of heart bypass surgery on patients for the first time. It demonstrated that non-invasive cardiac CT with AI-powered blood flow scanning is feasible and safe. Besides this, the widespread adoption of robotics and real-time imaging techniques facilitates the accurate placement of valves, stents, and other devices without the need for large incisions, which is also elevating the cardiovascular devices market revenue. For instance, in February 2024, Philips introduced LumiGuide, which is powered by Fiber Optic RealShape (FORS) technology, for radiation-free, minimally invasive surgeries. Apart from this, minimally invasive procedures are performed via small incisions using specialized cardiovascular instruments and advanced imaging techniques, which allow for targeted and precise treatments. Some of the common examples include transcatheter mitral valve repair (TMVR), transcatheter aortic valve replacement (TAVR), endoscopic vein harvesting, etc. Consequently, they are gaining traction across the globe. For example, in December 2022, Abbott, one of the leading global healthcare companies, announced the launch of its novel transcatheter aortic valve implantation (TAVI) system, Navitor, for individuals in India with severe aortic stenosis who are at high or extreme surgical risk. As technology advances, these procedures are becoming more effective and safer, thereby leading to their increasing adoption in treating numerous cardiovascular conditions. For instance, in May 2024, according to new one-year data presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI), a new biomimetic transcatheter aortic valve replacement (TAVR) system developed by Anteris Technologies can offer cardiologists with a new way to treat severe aortic stenosis (AS).

Introduction of Enhanced Variants

Cardiovascular devices play a crucial role in the treatment, diagnosis, and management of chronic heart conditions and stroke. Consequently, key players are launching novel devices that enable healthcare professionals to accurately assess the severity of cardiovascular diseases, monitor the heart health of patients, improve effective therapies, etc. Moreover, the increasing number of patients requiring intervention to address their cardiovascular conditions is escalating the popularity of smart stents, implantable pacemakers, defibrillators, etc. This, in turn, is positively influencing the cardiovascular devices market outlook. For example, in December 2023, Terumo India announced the launch of Ultimaster Nagomi, a drug-eluting stent intended for use in the treatment of coronary artery disease. Besides this, the growing investments in R&D activities to introduce improved cardiovascular devices, including pacemakers, are acting as significant growth-inducing factors. For instance, in May 2023, MicroPort, one of the global developers in the field of cardiac rhythm management, received FDA approval for its wide range of implantable pacemakers, Alizea and Celea. Additionally, they feature AutoMRI mode, an algorithm invented by MicroPort, that increases the safety of patients who are undergoing an MRI examination. Similarly, in July 2023, Abbott announced the FDA approval of its leadless pacemaker system, Aveir DR. Furthermore, machine learning and AI are employed for analyzing vast amounts of cardiovascular data to personalize treatment plans, predict patient outcomes, improve diagnostic accuracies, etc. For example, in January 2024, research led by Dr. Demilade Adedinsewo, one of the cardiologists at the Mayo Clinic in the U.S., suggested that the AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy, a potentially life-threatening condition that weakens the heart muscle of women during pregnancy.

Strategic Partnerships

Prominent companies, medical device manufacturers, research institutions, and healthcare organizations are collaborating and entering into mergers and acquisitions activities to introduce cardiovascular devices, including precise imaging tools. This represents one of the cardiovascular devices market recent opportunities. For instance, in September 2023, PaceMate, one of the leading cardiac data management platforms, announced the partnership with MedAxiom to create workflow solutions for cardiac and EHR data in a single, cloud-native environment. In line with this, in October 2023, GE HealthCare collaborated with Boston Scientific to develop enhanced cardiac imaging systems. Additionally, these partnerships aid companies in navigating complex regulatory landscapes and gaining access to international markets by leveraging the local expertise and established distribution networks of their partners. For example, in June 2023, Philips entered into a partnership with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Besides this, in May 2023, PaceMate collaborated with AliveCor, one of the global leaders in FDA-cleared personal electrocardiogram technology and remote patient management solutions, to encompass implantable cardiac devices.

Cardiovascular Devices Market Segmentation:

Breakup by Device Type:

  • Diagnostic and Monitoring Devices
  • Electrocardiogram (ECG)
  • Remote Cardiac Monitoring
  • Others
  • Therapeutic and Surgical Devices
  • Cardiac Rhythm Management (CRM) Devices
  • Catheter
  • Stents
  • Heart Valves
  • Others

Therapeutic and surgical devices is the most popular device type

The increasing number of surgical procedures and therapeutic interventions aimed at treating cardiovascular diseases is propelling the segment's growth. Moreover, therapeutic and surgical devices include implantable cardioverter defibrillators (ICDs), stents, pacemakers, catheters, heart valves, ventricular assist devices (VADs), etc. They aid in regulating heart rhythm, restoring blood flow, providing mechanical circulatory support, etc. Consequently, they are gaining extensive traction as less invasive alternatives to traditional open-heart surgeries, which is elevating the cardiovascular devices market demand. For example, in December 2023, Medtronic plc, one of the global leaders in healthcare technologies, announced the FDA approval of the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). In line with this, in June 2023, Magenta Medical launched a feasibility study for the world's smallest heart pump that reduces vascular access complications during heart surgery.

Breakup by Application:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

Coronary artery disease (CAD) dominates the cardiovascular devices market share

CAD devices used for treatment, diagnosis, and management of coronary artery disease condition are gaining traction across countries. Moreover, the widespread adoption of diagnostic devices, such as intravascular ultrasound (IVUS) devices, angiography systems, and computed tomography angiography (CTA) machines, as they help in assessing the severity of coronary artery blockages, is propelling the market. For example, in August 2022, Medtronic announced the launch of its novel drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following CE Mark approval. Besides this, in January 2024, Cleerly, one of the companies working to create a new standard of care for the diagnosis of heart disease, introduced Cleerly ISCHEMIA, which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance. Cleerly ISCHEMIA analysis software is an automated machine learning-based decision support tool specifically designed for patients undergoing coronary computed tomography angiography (CCTA).

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Hospitals account for the majority of the overall market share

Hospitals are the primary end users of cardiovascular devices. They provide a wide range of cardiac services, such as treatment, diagnosis, and surgical procedures for cardiovascular diseases. Hospitals have cardiac catheterization labs and specialized cardiology departments equipped with advanced imaging systems and surgical suites, which is increasing the cardiovascular devices market's recent price. For instance, in January 2024, Sylvia Jones, the health minister of Ontario, announced the development of a new cardiac lab at St. Mary's General Hospital in Kitchener, Canada, to help cardiac patients. They require a comprehensive range of devices, such as implantable devices, diagnostic equipment, surgical instruments, monitoring systems, etc., which is driving the growth in this segmentation.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest market for cardiovascular devices.

The increasing prevalence of cardiovascular conditions, including stroke and peripheral artery disease, is propelling the regional market. For instance, as per the report published by the Heart and Stroke Foundation of Canada in February 2022, there were 750,000 patients diagnosed with heart failure. Moreover, favorable reimbursement policies and fast regulatory approvals are acting as significant growth-inducing factors. For example, in September 2023, CorVista Health announced the FDA approval of its non-invasive medical device system that is used for detecting the presence of cardiac disease. In line with this, in January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received the U.S. FDA approval for its ASD Occluder for the treatment of atrial septal defects (ASDs). Apart from this, as per the cardiovascular devices market statistics, the introduction of wireless ECG has allowed for real-time patient monitoring and diagnosis. This, in turn, will continue to stimulate the regional market in the coming years. For example, in February 2021, VivaLNK developed a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).

Competitive Landscape:

The key players are investing significantly in R&D to develop innovative cardiovascular devices. They focus on improving device performance, durability, and patient outcomes. R&D efforts aim to introduce advanced technologies, such as minimally invasive procedures, remote monitoring systems, and personalized medicine approaches. Additionally, cardiovascular devices market companies are continuously launching new cardiovascular devices to expand their product portfolios. These launches often involve next-generation devices with improved features and enhanced capabilities. They are prioritizing addressing unmet clinical needs, such as novel therapies for specific cardiovascular conditions or devices that offer improved precision and ease of use. Besides this, collaborations and partnerships between key players, healthcare providers, and research institutions are common in the cardiovascular devices market. These collaborations foster innovation, facilitate knowledge exchange, and leverage collective expertise and resources to develop and commercialize new technologies and solutions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health Inc.
  • Edwards Lifesciences Corporation
  • General Electric Company
  • LivaNova Plc
  • Medtronic Plc
  • Siemens Healthineers GmbH (Siemens AG)
  • Terumo Cardiovascular Systems Corporation (Terumo Corporation)

Key Questions Answered in This Report

  • 1.What was the size of the global cardiovascular devices market in 2024?
  • 2.What is the expected growth rate of the global cardiovascular devices market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global cardiovascular devices market?
  • 4.What are the key factors driving the global cardiovascular devices market?
  • 5.What is the breakup of the global cardiovascular devices market based on the device type?
  • 6.What is the breakup of the global cardiovascular devices market based on the application?
  • 7.What is the breakup of the global cardiovascular devices market based on the end user?
  • 8.What are the key regions in the global cardiovascular devices market?
  • 9.Who are the key players/companies in the global cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Electrocardiogram (ECG)
      • 6.1.2.2 Remote Cardiac Monitoring
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.2.2 Catheter
      • 6.2.2.3 Stents
      • 6.2.2.4 Heart Valves
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Heart Failure
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Biotronik
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Canon Medical Systems Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Cardinal Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Edwards Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 General Electric Company
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 LivaNova PLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Medtronic PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers GmbH (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Cardiovascular Systems Corporation (Terumo Corporation)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cardiovascular Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cardiovascular Devices Market: Breakup by Device Type (in %), 2024
  • Figure 5: Global: Cardiovascular Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Cardiovascular Devices Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Cardiovascular Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cardiovascular Devices (Diagnostic and Monitoring Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cardiovascular Devices (Therapeutic and Surgical Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cardiovascular Devices (Coronary Artery Disease-CAD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cardiovascular Devices (Cardiac Arrhythmia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cardiovascular Devices (Heart Failure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cardiovascular Devices (Heart Failure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cardiovascular Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cardiovascular Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cardiovascular Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cardiovascular Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cardiovascular Devices (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cardiovascular Devices (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Cardiovascular Devices (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Cardiovascular Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Cardiovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Cardiovascular Devices Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Cardiovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Cardiovascular Devices Industry: SWOT Analysis
  • Figure 76: Global: Cardiovascular Devices Industry: Value Chain Analysis
  • Figure 77: Global: Cardiovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiovascular Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cardiovascular Devices Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 3: Global: Cardiovascular Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Cardiovascular Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Cardiovascular Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cardiovascular Devices Market: Competitive Structure
  • Table 7: Global: Cardiovascular Devices Market: Key Players